Amneal Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AMRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

243,133

Value ($000)

3,063

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,063	0.0%	243,133	12/31/2025
2025 Q3	11/14/2025	2,341	0.0%	233,895	9/30/2025
2025 Q2	8/14/2025	3,806	0.0%	470,432	6/30/2025
2025 Q1	5/19/2025	2,807	0.0%	334,956	3/31/2025
2024 Q4	2/14/2025	2,522	0.0%	318,420	12/31/2024
2024 Q3	11/14/2024	1,818	0.0%	218,554	9/30/2024
2024 Q2	8/14/2024	1,681	0.0%	264,724	6/30/2024
2024 Q1	5/15/2024	221	0.0%	36,429	3/31/2024
2023 Q2	8/11/2023	118	0.0%	84,912	6/30/2023
2023 Q1	5/15/2023	118	0.0%	84,912	3/31/2023
2022 Q4	2/14/2023	169	0.0%	84,912	12/31/2022
2022 Q3	11/14/2022	172	0.0%	84,912	9/30/2022
2022 Q2	8/12/2022	315	0.0%	98,985	6/30/2022
2022 Q1	5/16/2022	413	0.0%	98,985	3/31/2022
2021 Q4	2/14/2022	474	0.0%	98,985	12/31/2021
2021 Q3	11/15/2021	529	0.0%	98,985	9/30/2021
2021 Q2	8/16/2021	507	0.0%	98,985	6/30/2021
2021 Q1	5/14/2021	585	0.0%	86,949	3/31/2021
2020 Q4	3/1/2021	409	0.0%	89,605	12/31/2020
2020 Q3	11/13/2020	444	0.0%	114,514	9/30/2020
2020 Q2	8/14/2020	545	0.0%	114,514	6/30/2020
2020 Q1	5/15/2020	406	0.0%	116,728	3/31/2020
2019 Q4	2/14/2020	412	0.0%	85,537	12/31/2019